News

'Modern Family' star Eric Stonestreet talks weight loss, Mounjaro and facing stigma
First, he landed his role in "Modern Family," a critically acclaimed ABC sitcom that went on for 11 seasons and catapulted ...
Eric Stonestreet Says Mounjaro Was a ‘Game Changer’ for Type 2 Diabetes, Weight Loss: ‘There’s a Pep in My Step' (Exclusive)
Modern Family’ alum Eric Stonestreet opened up to PEOPLE about living with type 2 diabetes and being unable to get a grasp on ...
'Modern Family' star Eric Stonestreet reveals he's been taking Mounjaro for type 2 diabetes since 2022. It has changed his life in 2 ways.
Stonestreet was diagnosed with type 2 diabetes in 2009, but kept it a secret. He told Business Insider why he's speaking out ...
Why Eli Lilly Stock Is Sinking Today
Shares of Eli Lilly ( LLY -10.79%) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The leg down comes as ...
Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance
Eli Lilly's weekly prescription data for Zepbound is up 354% year over year while Novo Nordisk's Wegovy is up just 61%.
StockStory.org on MSN2d
Why Eli Lilly (LLY) Stock Is Nosediving
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 11% in the afternoon session after the company reported ...
Eli Lilly's Stock Is Up 15% This Year, and Here's Why It Could Take Off Even More
Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly ( LLY 1.09%).
ZAWYA3h
Lilly reports first-quarter 2025 financial results and highlights pipeline momentum
Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first-quarter of 2025.
pharmaphorum22h
Lilly hit as PBM drops Zepbound, but retains Wegovy
Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...